Biotechnology Industry Immersion

Crafted for future leaders, Graduate School of Management Biotechnology Industry Immersion combines cutting-edge biotechnology insights with advanced leadership and management training. Gain a robust understanding of the dynamic forces propelling the biotech industry forward.

You’ll learn from top industry executives through live cases about:

  • Growth and new developments
  • Drug innovations
  • Entrepreneurship
  • Drug regulations
  • Marketing and commercialization

Program Highlights

  • Curriculum designed by both UC Davis faculty and industry executives to reflect the latest challenges in the industry
  • Hands-on, problem-solving experiences each week with a team of MBA-biotech sciences student team
  • Five weeks of interactive classes taught by senior executives from a select group of companies
  • Group assignments in every class, examining potential solutions to management challenges
  • Merit-based scholarships are available to incoming MBA admits annually.

Testimonials

“Most MBA programs leverage cases to help bring texture to business concepts, but the Immersion program brings cases to life and lets you experience them.” – David Bodimer MBA 19

“It’s a fantastic opportunity for students to get some knowledge and classroom learning about the intersection between business, academia and biotechnology.” – Christopher Murriel, OncoMed Pharmaceuticals

Advisory Board

Member Affiliation Title
Steven Chamow Alira Health LLC Principal Consultant
Advisory Board Chair
David Dodds Dodds and Associates Consultant
Cory Berkland Washington University Professor and Entrepreneur

Travis Engleman

Danaher VP Business Development
Russ Lehrman Alira Health LLC Consultant and Entrepreneur
Niall O'Donnell Rivervest Ventures Venture Capitalist
John Selep Agtech Innovation Alliance Co-founder and Chairman
Sunita Dhar Genentech Executive Medical Group Director
Fernando Beils Qiagen Sr. VP, Molecular Diagnostics
Christian Borjesson Beckman Coulter (Danaher) President, Microbiology
Mimi Villanueva Biora Therapeutics Vice President PD Operations and Project Management

Recent Executive Speakers

Photo Gallery

Image
UC Davis graduate students in classroom
UC Davis graduate students discussing case study as part of the Biotechnology Industry Immersion
Image
Craig Shimasaki, President and CEO of Moleculera Labs
Craig Shimasaki, President and CEO of Moleculera Labs
Image
Glenn Nedwin, CEO and President of Second Genome
Glenn Nedwin, CEO and President of Second Genome
Image
Lonnie Bookbinder, CEO and founder of ARIZ Precision Medicine
Lonnie Bookbinder, CEO and founder of ARIZ Precision Medicine